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feedback on a 4 point scale for applicability, comprehensibility and appropriateness 
of the response options of each item. They were also encouraged to leave free-text 
feedback. Results: A total of 218 subjects provided feedback, 61.47% female. Mean 
age was 55.78 years, with patients from 18-80 years, 40.37% between 55-65 years. 
The most represented conditions were Parkinson’s (27), Fibromyalgia (23), Multiple 
Sclerosis (20) and Rheumatoid Arthritis (19). The mean number of quantitative 
assessments per item was 55.74, while the mean number of comments was 11.64. 
Considering a cut-off of 2 points in the 0-3 scale, 18 items had low applicability, 
just one item had low comprehensibility and all items had appropriate response 
options. ConClusions: An impressive amount of feedback was obtained in just 
a week using the Open Research Exchange platform. The lowest scores were in 
applicability. However, as the items are destined to an adaptive test, some of them 
are very extreme (destined to severe cases). Therefore applicability was considered 
a secondary concern. With this caveat, quantitative feedback was very positive, and 
added to the great amount and detail of qualitative feedback suggest some changes 
that we think will greatly improve the instrument.
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objeCtives: To measure and compare the quality of life in patients undergoing 
hemodialysis with respect to time. Methods: An observational, prospective study 
conducted in 2012/2013 consisting of 50 patients with Terminal Chronic Kidney 
Disease, undergoing HD in a public clinical care within the metropolitan area of 
Fortaleza. We used the KDQOL instrument early in therapy and one year after its 
beginning in order to observe changes in quality of life over time. Statistical analy-
sis included frequency distribution and measures of central tendency. Results: 
The general dimensions of this instrument indicate that the dimensions “physical 
function”, “social function” and “emotional function” had the lowest scores early 
in therapy. It is observed that these same dimensions showed significant improve-
ments in patients after one year of HD. Only “general health” was not significant. 
At baseline, specific dimensions of the instrument as “professional role”, “sexual 
function” and “disease overload” have the lowest scores and remain the same after 
one year of the begin of therapy, showing that the time difference has no statistical 
significance. ConClusions: The quality of life of patients undergoing hemodialysis 
after a year of therapy is superior to the quality of life showed at the beginning of 
treatment although this difference is not statistically significant. It is important 
to search for alternatives that can positively influence the quality of life of these 
patients.
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objeCtives: According to the methodology of the German Institute for Quality 
and Efficiency in Healthcare (IQWiG), the benefit assessment of a new treatment 
intervention refers to patient-reported outcomes exclusively. Given the existence of 
different patient-relevant outcomes the Federal Joint Committee (G-BA) can engage 
the IQWiG to aggregate these to one comprehensive benefit measurement. So far, 
the IQWiG uses no standardized method for this. In its current method paper, among 
the benefit QALY, the IQWiG refers to methods of multi-criteria decision making 
or preference evaluation like analytic hierarchy process and conjoint analysis. For 
psoriasis, one of the most frequent chronic skin diseases worldwide, a variety of 
treatment interventions is available. In the light of recent discussions, the objective 
was to give an overview of methods which have been used to date to prioritize and 
weight patient-relevant outcomes in psoriasis treatment. Methods: The present 
review is based on a systematic literature research until 31 December 2013 in the 
databases PubMed, Embase, Ovid Medliner, Cochrane Library, EconLit and CINAHL 
using the keywords “psoriasis” and “preferences”. Results: The search resulted in 
288 hits without duplicates. 16 articles met the predefined inclusion criteria. In addi-
tion to methods to calculate QALY like time-trade off and standard gamble, conjoint 
analysis, willingness-to-pay and other preference methods were used. In view of the 
method paper of IQWiG, no study exists in the field of psoriasis where the analytic 
hierarchy process was used. ConClusions: The results of the presented review 
show, that the analytic hierarchy process was not used in psoriasis studies, so far. 
The use of this method in future studies might provide new essential knowledge 
in the evaluation of patient preferences in psoriasis treatment.
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objeCtives: The QUALIOST (quality in life questionnaire in osteoporosis) is one of 
the most commonly used osteoporosis-specific health-related quality of life (HRQoL) 
questionnaires and it is often used in clinical studies to document the longitudinal 
impact of osteoporosis and related fractures. It is unknown whether the QUALIOST is 
better at estimating HRQoL for osteoporotic fracture patients compared to the com-
monly used EQ-5D questionnaire. Preference scores have not yet been developed for 
the QUALIOST and, thus, cost-utility analyses are difficult to perform. The purpose of 
the present paper is to describe the first steps of a future study on mapping from the 
QUALIOST to the EQ-5D questionnaire. Methods: A questionnaire, containing both 
EQ-5D-5L and QUALIOST, is distributed to patients in an orthopaedic outpatient clinic 
in Denmark and the aim is to include 150 patients. Patients above 50 years of age and 
with a recent fracture (less than 2 weeks old) are invited to participate in the study. 
effects associated with EQ-5D-5L, this measure is still not a key requirement for cost-
effectiveness modeling in selected HTA submissions. ConClusions: EQ-5D-3L has 
the potential to distort the true cost-effectiveness in conditions that are insensi-
tive to the measure. Awareness and requirements for the use of EQ-5D-5L should 
increase amongst manufacturers and HTA bodies to ensure submissions present 
accurate cost-effectiveness models. Further research into the evaluation of cost-
effectiveness results between these two measures following the introduction of 
validated independent value sets for EQ-5D-5L is encouraged.
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objeCtives: In patients requiring frequent blood transfusions due to transfusion 
dependent anemia (TDA) (e.g., sickle cell disease [SCD]) and myelodysplastic syn-
drome (MDS), life expectancy is directly related to the quality of chelation therapy, 
and poor adherence to treatment increases the risk of complications and shortens 
survival1. Improved palatability ratings and gastrointestinal (GI) tolerability could 
have positive impacts on adherence with iron chelation therapy (ICT) 2. Therefore, 
patient-reported outcomes (PROs) measuring compliance, GI symptoms, and pal-
atability were developed and the Satisfaction with Iron Chelation Therapy (SICT) 
questionnaire was modified, as electronic PROs (ePROs) specific to a new formula-
tion of ICT. Methods: Eleven patients with TDA or MDS provided informed con-
sent and were included in this qualitative study. Two sets of face-to-face cognitive 
interviews were conducted iteratively; modifications to items were debriefed in the 
second set. Interviews began open-endedly to elicit patients’ spontaneous experi-
ences with ICT. Interviews were audio recorded and transcribed. An item tracking 
matrix documented the changes made for each item. Data analysis used ATLAS. ti 
software. This study was conducted according to best practices for development3 
and modification4 of PROs in an ePRO format. Results: Patients were 73% (n= 8) 
male and 27% (n= 3) female with a mean age of 43 (range 14-81 years); 45% (n= 5) had 
SCD, and 27% (n= 3) had MDS. Patient spontaneous reports and cognitive debriefing 
responses confirmed concepts in the draft PROs and helped eliminate irrelevant 
items. Changes made after cognitive debriefing ensured the comprehensibility, lack 
of redundancy, and appropriate instructions and response options. The resultant 
PROs included the Compliance (2 items), GI Symptom Diary (6 items), Palatability (4 
items), and modified SICT (13 items). ConClusions: Results support the content 
validity of PRO measures of compliance, GI symptoms, palatability, and satisfaction 
with ICT. These measures require psychometric validation of validity, reliability, and 
responsiveness before recommending their use in future clinical research.
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objeCtives: As the use of clinical outcomes assessments (COAs) in global studies 
continues to increase, early collaboration between eCOA and linguistic validation 
providers becomes critical to the success of global initiatives. Early involvement 
of a linguistic validation partner in the eCOA migration process offers insight into 
migration issues that may not be present in the English version of the instrument, 
but if not identified, can lead to study delays as well as increased costs for the spon-
sor. Methods: An examination was conducted of previous linguistic validation 
projects that included either newly developed eCOA instruments or pen/paper to 
eCOA migration. A comparison of various eCOA platforms, the corresponding issues, 
and details relating to migration solutions were assessed. Results: Frequently, a 
line of text that is present in an eCOA platform (proprietary software, Excel, etc.) 
is coded such that it populates into the eCOA device in multiple locations. These 
segments are sometimes referred to as “computed text” and are commonly used 
for response options that repeat for multiple items of a questionnaire. While this 
may work adequately in English, many languages require a variance in the transla-
tion used based on the context of the item and/or response choice. While a pen/
paper version may allow for these variances, the initial eCOA programming may 
not. The variance is only determined further into the linguistic validation process 
and presents challenges if the device requires re-programming. ConClusions: A 
migration assessment, separate from equivalency testing, allows for the eCOA and 
linguistic validation providers to assess the initial setup of the eCOA software. This 
assessment can determine whether system modifications are necessary to allow 
for the translations to properly be mapped and displayed. This additional step will 
also prevent study delays as well as quality issues as it allows issues to be addressed 
early and avoid later difficulties.
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objeCtives: CAT-Health is a generic health related quality of life computer adaptive 
test developed and validated in Spain. Based on its 96 item pool, a new instrument 
is being developed in English. The objective of the present study was to obtain 
substantial feedback from patients on the items, through Open Research Exchange 
platform, that centralizes PROM research and is integrated with PatientsLikeMe, 
an online community. Methods: The item pool was split in four sets of 24 items 
each. 750 patients with various conditions received an e-mail that included link 
to a survey open for 7 days. They were asked to answer one of the sets and give 
